146 Researchers at the Indian Institute of Technology (IIT) in Madras, Tel Aviv University, and Columbia University are working to develop a treatment for a rare genetic brain disease called GNB1 Encephalopathy. This neurological disorder affects fetuses and has fewer than 100 documented cases worldwide. Symptoms of GNB1 Encephalopathy include delayed physical and mental development, intellectual disabilities, and frequent epileptic seizures. Due to the high cost of genome sequencing, not many parents opt for it early on, making it difficult to diagnose and treat the disease in its early stages. You Might Be Interested In India and Bangladesh Deliberate on Deteriorating Security Conditions in Myanmar Mumtalakat Funds Singapore Gulf Bank to Expand Presence in Bahrain South Korea penalizes Tesla for misrepresenting EV Range ExxonMobil Advances Whiptail Development in Guyana Thailand’s emerging new political alignment India, aspiring for digital dominance, persistently shuts down the internet